FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare 5% Dextrose Injection Recall

5% Dextrose Injection, USP, in VIAFLEX Plastic Container Multi Pack, Rx Only, a) 50 mL…

Baxter Healthcare Corp. · Deerfield, IL

Risk level
Class II
Reported by FDA
Jul 10, 2013
Recall ID
D-625-2013
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled 5% Dextrose Injection starting May 21, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-625-2013 on Jul 10, 2013. Reason: Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Product description

5% Dextrose Injection, USP, in VIAFLEX Plastic Container Multi Pack, Rx Only, a) 50 mL (NDC 0338-0017-31), b) 100 mL (NDC 0338-0017-38), Baxter, Deerfield, IL 60015

Lot numbers, UPCs & expiration codes

Lot #: a) Product code 2B0088: P280115, P285239, Exp 7/13; b) Product code 2B0089: P280230, P280461, P285288, P285288A, P285783, Exp 8/13

Where it was sold

Nationwide & Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-625-2013
Classification
Class II
Status
Terminated
Recall initiated
May 21, 2013
FDA report date
Jul 10, 2013
Quantity
730,848 units
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corp.

Original FDA data

Every field from FDA enforcement report D-625-2013, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
65288
Address
1 Baxter Pkwy
Code information
Lot #: a) Product code 2B0088: P280115, P285239, Exp 7/13; b) Product code 2B0089: P280230, P280461, P285288, P285288A, P285783, Exp 8/13
Postal code
60015-4625
Report date
Jul 10, 2013
Product type
Drugs
Recall number
D-625-2013
Classification
Class II
Recalling firm
Baxter Healthcare Corp.
Product quantity
730,848 units
Termination date
Jun 18, 2015
Reason for recall
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
Voluntary / mandated
Voluntary: Firm initiated
Product description
5% Dextrose Injection, USP, in VIAFLEX Plastic Container Multi Pack, Rx Only, a) 50 mL (NDC 0338-0017-31), b) 100 mL (NDC 0338-0017-38), Baxter, Deerfield, IL 60015
Distribution pattern
Nationwide & Puerto Rico
Recall initiation date
May 21, 2013
Initial firm notification
Letter
Center classification date
Jun 28, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-625-2013, published Jul 10, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls